These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 12623895)
1. US drug sales continue to rise. Gottlieb S BMJ; 2003 Mar; 326(7388):518. PubMed ID: 12623895 [No Abstract] [Full Text] [Related]
2. Market watch: Specialty pharmaceuticals to provide majority of sales by 2012. Goodman M Nat Rev Drug Discov; 2009 Mar; 8(3):184. PubMed ID: 19247297 [No Abstract] [Full Text] [Related]
3. Making the move into drug sales. Willerroider M Nature; 2004 Jul; 430(6998):486-7. PubMed ID: 15269778 [No Abstract] [Full Text] [Related]
4. How insurers' bargaining power affects drug prices in Medicare Part D. Natl Bur Econ Res Bull Aging Health; 2009; (4):1-2. PubMed ID: 20355274 [No Abstract] [Full Text] [Related]
5. Sales from licensed and acquired products to increase by 2013. Goodman M Nat Rev Drug Discov; 2009 Jun; 8(6):443. PubMed ID: 19483704 [No Abstract] [Full Text] [Related]
6. Top 20 pharmaceutical companies. Ranked by U.S. sales, December 2005 to November 2006. Mod Healthc; 2007 Jan; 37(2):33. PubMed ID: 17243346 [No Abstract] [Full Text] [Related]
7. By the numbers. Top 20 pharmaceutical companies. Ranked by U.S. sales, April 2003 through March 2004. Moon S Mod Healthc; 2004 Aug; 34(33):40. PubMed ID: 15356990 [No Abstract] [Full Text] [Related]
8. Pharmaceuticals and medical devices: business practices. ; Steiner DJ Issue Brief Health Policy Track Serv; 2014 Dec; ():1-38. PubMed ID: 25771555 [No Abstract] [Full Text] [Related]
9. Strategies for developing and commercializing nanobio drugs, diagnostics and devices. Bunger M Nanomedicine (Lond); 2007 Apr; 2(2):137-41. PubMed ID: 17716115 [No Abstract] [Full Text] [Related]
10. Pharmaceutical industry financial performance. Goodman M Nat Rev Drug Discov; 2009 Dec; 8(12):927-8. PubMed ID: 19949398 [No Abstract] [Full Text] [Related]
11. Market watch: Top drugs and companies by sales in 2017. Urquhart L Nat Rev Drug Discov; 2018 Mar; 17(4):232. PubMed ID: 29588516 [No Abstract] [Full Text] [Related]
12. Can complexity be commercialized? Mack GS Nat Biotechnol; 2004 Oct; 22(10):1223-9. PubMed ID: 15470456 [No Abstract] [Full Text] [Related]
13. FDA chief attacks Canada's drug price controls. Webster P Lancet; 2003 Nov; 362(9398):1816. PubMed ID: 14661624 [No Abstract] [Full Text] [Related]
14. Bringing business risk into sharp focus. Gruber B; Walsh E Nat Biotechnol; 2012 Jan; 30(1):30-2. PubMed ID: 22231088 [No Abstract] [Full Text] [Related]
15. Patent indicators: a window to pharmaceutical market success. Guo Y; Hu Y; Zheng M; Wang Y Expert Opin Ther Pat; 2013 Jul; 23(7):765-71. PubMed ID: 23611022 [TBL] [Abstract][Full Text] [Related]
16. Predictions and Statistics for the Best-Selling Drugs Globally and in the United States in 2018 and a Look Forward to 2024 Projections. Lindsley CW ACS Chem Neurosci; 2019 Mar; 10(3):1115. PubMed ID: 30889957 [No Abstract] [Full Text] [Related]
17. Looking inward: regional parallel trade as a means of bringing affordable drugs to Africa. Buckely M Seton Hall Law Rev; 2011; 41(2):625-69. PubMed ID: 21739760 [No Abstract] [Full Text] [Related]
18. Top 20 pharmaceutical companies. Ranked by U.S. sales, October 2007 to September 2008. Mod Healthc; 2009 Jan; 39(1):32. PubMed ID: 19226860 [No Abstract] [Full Text] [Related]
19. By the numbers. Top 20 pharmaceutical companies ranked by U.S. sales, November 2003 to October 2004. Moon S Mod Healthc; 2005 Jan; 35(1):32. PubMed ID: 15693520 [No Abstract] [Full Text] [Related]